Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Buys C$31,277.77 in Stock

Cardiol Therapeutics Inc. (TSE:CRDL) Senior Officer Guillermo Torre purchased 17,240 shares of the stock in a transaction that occurred on Thursday, December 26th. The shares were purchased at an average price of C$1.81 per share, for a total transaction of C$31,277.77.

Cardiol Therapeutics Price Performance

Shares of TSE:CRDL opened at C$1.89 on Friday. The firm has a market capitalization of C$132.07 million, a PE ratio of -4.30 and a beta of 0.70. The company has a current ratio of 2.39, a quick ratio of 6.84 and a debt-to-equity ratio of 1.07. Cardiol Therapeutics Inc. has a 1-year low of C$1.09 and a 1-year high of C$4.26. The business’s 50 day moving average is C$2.29 and its 200-day moving average is C$2.63.

About Cardiol Therapeutics

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.